Among the 334 CRC cases, amplification of EGFR, HER2, c-MYC, and MET was observed in 8 (2.4%), 20 (6.0%), 29 (8.7%) and 14 (4.2%) cases, respectively. The gene discussed is MYC; the disease is colorectal carcinoma.